ABM has launched its ABM Connect™ for Life Sciences compliance and digital regulatory reporting platform to support more than 300 MedTech companies and 85+ biopharma firms domiciled in the Republic of Ireland.
Replacing paper-based documentation with a secure, fully digital system that creates an instant, audit-ready record of all activities, the solution guides frontline teams through cleaning, maintenance, and operational protocols to ensure conformity with the European Medicines Agency’s Annex 11 guidelines for electronic records and electronic signatures.
The system is accessed via a secure mobile application on company-issued devices, giving authorised personnel immediate access to live schedules, standard operating procedures (SOPs), and task instructions.
It also features real-time, automated task management and verification, ensuring that work is completed according to validated processes by trained and compliant staff.
Supporting Compliance in a Highly Regulated Sector
Manual documentation and logbooks in life sciences facilities can be time-consuming, prone to error, and costly to maintain.
ABM Connect for Life Sciences digitises and centralises these records, helping companies reduce the likelihood of deviations, minimise rework, and improve oversight.
“Clients across the life sciences landscape are under pressure to deliver efficiency without compromising safety or compliance,” says Dinny Crowe, Vice President, Operations, ABM. “ABM Connect for Life Sciences builds on decades of sector expertise to provide a precision-driven, validated process that gives our clients real-time visibility into operations and readiness for inspection at any time.”
Clients who utilise ABM Connect for Life Sciences state that it has improved their documentation compliance while reducing the costs and environmental impact of maintaining paper logbooks.
It is a smarter, more sustainable approach to compliance.
A Strategic Expansion into Ireland
The launch represents a significant step in ABM’s growth within Ireland’s life sciences sector, where the company is expanding its specialist services.
Globally, the integrated facility services provider supports more than 85 million square feet of life sciences facilities daily, with over 500 GMP-trained team members working in highly regulated, controlled environments.
The group is an active member of leading life sciences professional associations, including the International Society of Pharmaceutical Engineers (ISPE), Institute of Environmental Sciences and Technology (IEST), Massachusetts Biotechnology Council (MassBio), BioCom California, and INTERPHEX.
With more than 25 years of life sciences expertise, ABM’s Irish team delivers tailored, end-to-end support, combining global best practices with deep regulatory knowledge to meet the unique needs of pharmaceutical, biotech, and medical device manufacturers.
ABM Connect for Life Sciences is already in use across the United States with some of the world’s leading pharmaceutical and biotech companies,
